Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcce39a20bef16c3f04497659caba40f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd43e12353298376fd7642260c1dbca |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
filingDate |
2020-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5376f339dcf77961206c73685a5cea28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91b8d802f6408220b3f65d18839f1467 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e75be40e5aef6b9a1c4011f1f0a1db66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc18cd7370f4b6ef84cc4eda226d594c |
publicationDate |
2022-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-112022008683-A2 |
titleOfInvention |
DOSAGE SCHEMES FOR USE IN THE TREATMENT OF MYELOFIBROSIS AND MPN-RELATED DISORDERS WITH NAVITOCLAX |
abstract |
DOSAGE SCHEMES FOR USE IN THE TREATMENT OF MYELOFIBROSIS AND MPN-RELATED DISORDERS WITH NAVITOCLAX. The invention described herein relates to methods for treating a human subject with myelofibrosis or an MPN-related disorder, which comprises administering navitoclax to the subject optionally in combination with ruxolitinib. |
priorityDate |
2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |